139 related articles for article (PubMed ID: 28941610)
21. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
Miramontes-González JP; Usategui-Martín R; Pérez de Isla L; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Jiménez FF; Martín-Vallejo J; Rodríguez Gude AE; Jiménez DL; Padro T; González-Sarmiento R; Mata P
Atherosclerosis; 2019 Jun; 285():17-22. PubMed ID: 30991288
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH
Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872
[TBL] [Abstract][Full Text] [Related]
23. Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis.
Ellis KL; Pang J; Chieng D; Bell DA; Burnett JR; Schultz CJ; Hillis GS; Watts GF
Clin Cardiol; 2018 Mar; 41(3):378-384. PubMed ID: 29480541
[TBL] [Abstract][Full Text] [Related]
24. Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.
Brænne I; Kleinecke M; Reiz B; Graf E; Strom T; Wieland T; Fischer M; Kessler T; Hengstenberg C; Meitinger T; Erdmann J; Schunkert H
Eur J Hum Genet; 2016 Feb; 24(2):191-7. PubMed ID: 26036859
[TBL] [Abstract][Full Text] [Related]
25. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
[TBL] [Abstract][Full Text] [Related]
26. Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia.
Bos S; Phillips M; Watts GF; Verhoeven AJM; Sijbrands EJG; Ward NC
J Clin Lipidol; 2017; 11(3):682-693. PubMed ID: 28434814
[TBL] [Abstract][Full Text] [Related]
27. Defining patients at extremely high risk for coronary artery disease in heterozygous familial hypercholesterolemia.
Sugisawa T; Okamura T; Makino H; Watanabe M; Kishimoto I; Miyamoto Y; Iwamoto N; Yamamoto A; Yokoyama S; Harada-Shiba M
J Atheroscler Thromb; 2012; 19(4):369-75. PubMed ID: 22333410
[TBL] [Abstract][Full Text] [Related]
28. Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.
Ten Kate GR; Bos S; Dedic A; Neefjes LA; Kurata A; Langendonk JG; Liem A; Moelker A; Krestin GP; de Feyter PJ; Roeters van Lennep JE; Nieman K; Sijbrands EJ
J Am Coll Cardiol; 2015 Dec; 66(24):2687-2695. PubMed ID: 26700830
[TBL] [Abstract][Full Text] [Related]
29. ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia.
Paquette M; Dufour R; Baass A
J Clin Lipidol; 2018; 12(2):383-389.e1. PubMed ID: 29290540
[TBL] [Abstract][Full Text] [Related]
30. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
[TBL] [Abstract][Full Text] [Related]
32. Assessment of arterial stiffness in patients with familial hypercholesterolemia.
Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M
J Clin Lipidol; 2018; 12(2):397-402.e2. PubMed ID: 29292049
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.
Chen Q; Reis SE; Kammerer C; Craig WY; LaPierre SE; Zimmer EL; McNamara DM; Pauly DF; Sharaf B; Holubkov R; Bairey Merz CN; Sopko G; Bontempo F; Kamboh MI
Circulation; 2003 Jul; 107(25):3146-51. PubMed ID: 12810610
[TBL] [Abstract][Full Text] [Related]
34. On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease.
Trabetti E; Biscuola M; Cavallari U; Malerba G; Girelli D; Olivieri O; Martinelli N; Corrocher R; Pignatti PF
Eur J Hum Genet; 2006 Jan; 14(1):127-30. PubMed ID: 16251892
[TBL] [Abstract][Full Text] [Related]
35. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
36. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
[TBL] [Abstract][Full Text] [Related]
37. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG
Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343
[TBL] [Abstract][Full Text] [Related]
38. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
Rahman T; Hamzan NS; Mokhsin A; Rahmat R; Ibrahim ZO; Razali R; Thevarajah M; Nawawi H
Lipids Health Dis; 2017 Apr; 16(1):81. PubMed ID: 28438163
[TBL] [Abstract][Full Text] [Related]
39. Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD.
Knowles JW; Assimes TL; Boerwinkle E; Fortmann SP; Go A; Grove ML; Hlatky M; Iribarren C; Li J; Myers R; Risch N; Sidney S; Southwick A; Volcik KA; Quertermous T
BMC Med Genet; 2008 Apr; 9():23. PubMed ID: 18384690
[TBL] [Abstract][Full Text] [Related]
40. The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia.
Ten Kate GJ; Neefjes LA; Dedic A; Nieman K; Langendonk JG; Galema-Boers AJ; Roeters van Lennep J; Moelker A; Krestin GP; Sijbrands EJ; de Feyter PJ
Atherosclerosis; 2013 Apr; 227(2):334-41. PubMed ID: 23369702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
